SCHEMBL4409266

SCHEMBL4409266

C[C@H](O)S(N)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL160213 1.00
Sulfamate SCHEMBL28304617 0.77
SCHEMBL18254464 0.76
SCHEMBL20792925 0.76
SCHEMBL18474671 0.76
SCHEMBL18254250 0.76
SCHEMBL43258 0.75
SCHEMBL21766997 0.74
SCHEMBL2219991 0.72
SCHEMBL8083316 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4289481-B1 METHOD OF SYNTHESIZING (3S,3AR,5R,7AS,8S)- HEXAHYDRO-4H-3,5-METHANOFURO[2,3-B]PYRAN-8-OL PURDUE RESEARCH FOUNDATION (US) 2025-09-17 EP disclosed
US-12365691-B2 Method of synthesizing (3S,3AR,5R,7AS,8S)-hexahydro-4H-3,5-methanofuro[2,3-b]pyran-8-ol PURDUE RESEARCH FOUNDATION (US) 2025-07-22 US disclosed
US-20230399338-A1 METHOD OF SYNTHESIZING (3S,3AR,5R,7AS,8S)- HEXAHYDRO-4H-3,5-METHANOFURO[2,3-b]PYRAN-8-OL NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-12-14 US disclosed
EP-4289481-A1 METHOD OF SYNTHESIZING (3S,3AR,5R,7AS,8S)- HEXAHYDRO-4H-3,5-METHANOFURO[2,3-B]PYRAN-8-OL Purdue Research Foundation (US) 2023-12-13 EP disclosed
US-9309213-B2 C-3 substituted bicyclooctane based HIV protease inhibitors PURDUE RESEARCH FOUNDATION (US) 2016-04-12 US disclosed
US-20140148508-A1 C-3 SUBSTITUTED BICYCLOOCTANE BASED HIV PROTEASE INHIBITORS NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) 2014-05-29 US disclosed
WO-2013009844-A2 C-3 SUBSTITUTED BICYCLOOCTANE BASED HIV PROTEASE INHIBITORS PURDUE RESEARCH FOUNDATION (US) 2013-01-17 WO disclosed
EP-1709037-B1 HIV PROTEASE INHIBITING SULFONAMIDES ABBOTT LAB (US) 2009-12-23 EP disclosed